Biocon Biologics Phils

BIOCON BIOLOGICS LIMITED

Featured products of Biocon Biologics Ltd
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
trastuzumab
Packing/Price
(+ 1.1% bacteriostatic water for inj as diluent) 50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab
Packing/Price
(+ 10-mL diluent) 15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
Distributed by Biocon Biologics Phils
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
bevacizumab
Packing/Price
1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
trastuzumab
Packing/Price
(+ 1.1% bacteriostatic water for inj as diluent) 50 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.
trastuzumab
Packing/Price
(+ 10-mL diluent) 15 mL x 1's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01FD01 - trastuzumab : Belongs to the class of HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors. Used in the treatment of cancer.

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in